October 13-14, 2021 | 9:00AM EDT | 1:00PM UTC | 3:00PM CEST*
*Program is in development and subject to change
The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 3 months following the event.
Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest. Application must be completed by February 1, 2022.
This eSymposia is organized in collaboration with the Vitamin D Workshop, the premier meeting in the field of vitamin D biology since 1973. This virtual 23rd Vitamin D Workshop will accelerate scientific discoveries that optimize the health effects of the vitamin D endocrine system.
Ever since E.V. McCollum coined the term “vitamin D” in the 1920s, we’ve known that vitamin D plays an essential role in bone and calcium metabolism. However, decades of research show that vitamin D can also impact physiological and pathological processes beyond bone. As a molecular regulator of cell differentiation, lineage determination, apoptosis, autophagy, and metabolism, Vitamin D influences carcinogenesis, metabolic diseases, and various aspects of immunity. Meanwhile, the presence of the Vitamin D receptor and multiple metabolizing enzymes in most human tissues highlights the complexity of this system as a modulator of health and wellness throughout the body.
This virtual conference will be a venue for sharing insight into the molecular actions and translational potential of vitamin D in a variety of disease-relevant physiologic contexts, covering the following key scientific questions:
By answering these and other questions, participants will generate new scientific ideas and form collaborations that enable translation of this knowledge to improve human health.
‣ For Short Talk Consideration: Passed
‣ For ePoster Presentation: Passed
Final ePoster / SciTalk Submission: Passed
Financial Aid Application: Passed
*Abstract submission is required in order to submit an ePoster and/or Scitalk
[Pedro L. Alonso, MD, PhD]
[World Health Organization, Director of the Global Malaria Programme]
University of Alberta, Canada
Washington University, USA
Moray J. Campbell
Ohio State University, USA
Margherita T. Cantorna
Pennsylvania State University, USA
Ulster University, UK
Philip R. Fischer
Mayo Clinic, USA
Laurie J. Goodyear
Joslin Diabetes Center, Harvard Medical School, USA
University of North Carolina, Chapel Hill, USA
Seth W. Kullman
North Carolina State University, USA
University of Colorado, USA
Queen Mary University of London, UK
Institut de Génétique et de Biologie Moléculaire et Cellulaire, France
Roswell Park Comprehensive Cancer Center, USA
Baylor College of Medicine, USA
Funding for this conference was made possible, in part, by R13 AG048689-06 ("Annual Vitamin D Workshops") from the National Institute on Aging. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.
This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.